Incereb Ltd.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Incereb Ltd. - overview

Established

2012

Location

Dublin, -, Ireland

Primary Industry

Medical Devices & Equipment

About

Incereb Ltd. is a Dublin-based company specializing in innovative EEG solutions, focusing on providing advanced neurological monitoring and analysis tools for healthcare applications. Founded in 2012, Incereb Ltd. operates in the field of neurodiagnostics, primarily offering EEG services and products.


The company has successfully completed 2 deals, including their most recent funding round in March 2018, where they raised EUR 0. 75 million through a Seed round from Halo Business Angel Network. The headquarters is located in Dublin, Ireland. Incereb Ltd.


specializes in offering advanced EEG solutions, including EEG amplifiers, cloud software, and iEEG software, aimed at improving the efficiency of diagnosing neurological conditions. Their products support hospitals, neurology practices, and clinical trial sponsors in enhancing patient care through remote monitoring and analysis of brain activity, catering to clients across the United States, the United Kingdom, and Ireland. In 2020, Incereb Ltd. reported a revenue of EUR 31,720.


40, while their EBITDA for the year 2021 stood at EUR -130,585. 90. Their revenue model is primarily B2B, with income generated from the sale of their EEG products and subscription services to healthcare institutions. Incereb Ltd.


plans to leverage the EUR 0. 75 million raised in March 2018 to expand its product offerings and enter new markets. The company is focusing on developing new EEG technologies and aims to launch these products by the end of 2023. Additionally, Incereb is exploring opportunities to expand into new international markets, particularly in Europe and North America, to enhance its reach and provide innovative solutions for neurological diagnostics.


Current Investors

ACT Venture Capital, Delta Partners, Enterprise Ireland

Primary Industry

Medical Devices & Equipment

Sub Industries

Monitoring Equipment

Website

www.incereb.com

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.